Pediatric breast cancer rates are low, but guidelines exist to help alleviate patient concerns.
Roughly 12% of women will receive a breast cancer diagnosis in their lifetimes. Only 1% of men will get the same news. Even fewer children-less than 1/100th a percent-develop the condition.
But, thanks to breast cancer awareness campaigns, alertness and anxiety surrounding this disease continue to grow, including among parents. Their concern when a suspicious finding appears in a diagnostic screening test makes it critical that you understand whether and how to use breast ultrasound in such a young population. It can be a useful tool in identifying any abnormality in pediatric breast tissue.
To devise how best to tackle this issue, the University of California at Los Angeles (UCLA) and Children’s Hospital Los Angeles collaborated to improve pediatric breast ultrasound reporting and recommendations. They conducted a literature review to identify best practices in pediatric breast ultrasound, and they reviewed the final pathology reports from 76 pediatric breast ultrasounds performed within their institution.
Their results were published in a 2017 Journal of the American College of Radiology article. Prior to their publication, no formalized guidelines for using breast ultrasound in the pediatric population existed. The team defined pediatric population as any patient under the age of 21.
“We created standardized recommendations for common breast ultrasound findings in the pediatric population based on the results of our literature search for best practices,” wrote Aarti Luhar, MD lead study author and diagnostic and interventional radiologist with UCLA Medical Center. “We believe that offering consistent, specific recommendations will help decrease unnecessary follow-up for pediatric patients.”
Related article: Physical Exam Not Augmented by Breast Ultrasound in Younger Women
The drafted recommendations were reviewed by a multi-disciplinary board, including a board certified pediatric radiologist, a board-certified breast-imaging radiologist, and a board-certified pediatric surgeon.
In the pediatric population, breast ultrasound is the preferred screening modality for a variety of reasons. Not only does it provide adequate screening for dense breast tissue, but it doesn’t expose children to ionizing radiation that could harm immature glandular tissue like a mammogram or tomosynthesis would. And while an MRI doesn’t introduce radiation, children frequently must be sedated to undergo the procedure, making it neither time- nor cost-effective.
According to Luhar’s study team, BI-RADS shouldn’t be used to report findings in the pediatric population because the classification system overstates the risks of malignancy, particularly for categories 3 and 4.
All total, the team drafted seven recommendations based both on age and clinical finding.
Overall, Luhar says, specific recommendations could decrease any prolonged imaging or procedural work-up. As a result, patient and parent anxiety could fall, and cost savings could be generated by avoiding unneeded, additional imaging.
Study Finds Transvaginal Ultrasound Unreliable for Detecting Endometrial Cancer in Black Patients
July 3rd 2024Utilizing a threshold of less than 5 mm of ultrasound-measured endometrial thickness, the authors of a new study noted an 11.4 percent false-negative probability for endometrial cancer in Black patients.
AMA Issues 2025 Category III CPT Code for the ECG-Based AI Platform EchoGo Heart Failure
July 2nd 2024The EchoGo Heart Failure platform is reportedly the only AI-powered technology to receive a CPT reimbursement code for echocardiography detection of heart failure with preserved ejection fraction.
FDA Clears Pocket-Sized ECG System and AI Technology for Detection of Cardiac Conditions
June 27th 2024Using a reduced leadset and deep neural network algorithms trained on more than 175 million electrocardiograms, the KAI 12L technology reportedly detects up to 35 cardiac determinations, including acute myocardial infarction.